Health Science Center’s President’s Gala to help establish Institute for Alzheimer and Neurodegenerative Medicine

Breaking News
6019

Translate to Spanish or other 102 languages!

William L. Henrich, M.D., president of the UT Health Science Center San Antonio, visits with Alonzo Cantu, president of Cantu Construction.
William L. Henrich, M.D., president of the UT Health Science Center San Antonio, visits with Alonzo Cantu, president of Cantu Construction.

Mega Doctor News

- Advertisement -

William L. Henrich, M.D., president of the UT Health Science Center San Antonio, visits with Alonzo Cantu, president of Cantu Construction. The two were attending the Health Science Center’s President’s Gala held Sept. 26, which will help establish South Texas’ first Institute for Alzheimer and Neurodegenerative Medicine. the new institute is expected to open in 2016.

William L. Henrich, M.D., president of the UT Health Science Center San Antonio, left, is seen with with Alonzo Cantu, president of Cantu Construction.

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Valley Grande Institute’s expansion to Raymondville brings new vocational medical educational programs
Next article
Mesothelioma Cases are Steadily Increasing, Notes Mesothelioma Website

More Articles

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

The U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access to Affordable Medicines & Medical Products.

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.

Texas Oncology Expands Cancer Care With New McAllen West Clinic

Texas Oncology celebrated the grand opening of its McAllen West clinic Sept. 29, expanding cancer treatment, diagnostic, and research capabilities in the Rio Grande Valley as the organization continues its presence in the region, spanning more than 40 years.

Multicancer Blood Test Detects 17 Cancer Types in Large Prospective Study

A large prospective study published in Nature Medicine found that a blood test designed to detect multiple cancers identified cancer signals across 17 broad cancer types, such as ovarian, lung, breast and colorectal cancers, and many which do not have recommended screening tests.
- Advertisement -